Our hypotheses offer speculation on the potential utilization of PSGL-1 as a marker for immune suppression, a marker for inflammation and/or translocation, a marker for cell exhaustion, and a marker for potential or latent neoplastic disease during HIV infection. This evidence concerns the gene SELPLG and neoplasm.